GlassScriptPhysician profile
Michael L Mcclelland
NPI 1790782084
$8,016.62
in general payments reported to CMS, 2019-2025
45 companies · $3,590 in 2025
The $3,590 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $550 · 2021: $904 · 2022: $574 · 2023: $683 · 2024: $894 · 2025: $3,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,851 · Consulting Fee: $1,266 · Education: $35.06 · Entertainment: $16.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,850.52 |
| Consulting Fee | $1,266.00 |
| Education | $35.06 |
| Entertainment | $16.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,642.82 | 2019-2025 | Adstiladrin |
| Janssen Biotech, INC. | $1,323.46 | 2019-2025 | Erleada, Balversa, Rybrevant |
| Abbvie INC. | $621.39 | 2019-2025 | |
| Astellas Pharma US INC | $543.19 | 2019-2022 | |
| Endo USA, INC. | $473.12 | 2024-2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $356.32 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $301.19 | 2019-2024 | Rezum Generator |
| Pfizer INC. | $291.77 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $244.44 | 2019-2025 | |
| Urogen Pharma, INC. | $142.23 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $131.23 | 2019-2023 | Aveed, Xiaflex |
| Allergan, INC. | $130.34 | 2019-2021 | |
| Clarus Therapeutics INC. | $128.71 | 2021 | |
| Olympus America INC. | $105.30 | 2023-2024 | Itind System |
| Blue Earth Diagnostics | $99.82 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcclelland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.